|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 531.99 USD | -2.62% |
|
+0.45% | -5.28% |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| 06-05 | PriorNilsson Evolve Global rose 3.64 percent in May - trimmed positions in Beijer Alma and OEM | FW |
| Market Cap | 15.6B 13.67B 12.61B 11.65B 22.11B 1,491B 22.51B 151B 58.81B 731B 58.59B 57.3B 2,536B | P/E 2026 * |
31.4x | P/E 2027 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise Value | 14.43B 12.64B 11.66B 10.78B 20.45B 1,379B 20.82B 140B 54.4B 676B 54.2B 53.01B 2,346B | EV / Sales 2026 * |
5.2x | EV / Sales 2027 * | 4.74x |
| Free-Float |
80.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | -2.62% | ||
| 1 week | +0.45% | ||
| Current month | +0.45% | ||
| 1 month | +17.11% | ||
| 3 months | +4.62% | ||
| 6 months | -13.23% | ||
| Current year | -5.28% |
| 1 week | 520.88 |  | 567.91 |
| 1 month | 445 | | 567.91 |
| Current year | 373 | | 628.92 |
| 1 year | 306.7 | | 628.92 |
| 3 years | 227.21 | | 628.92 |
| 5 years | 126.94 | | 628.92 |
| 10 years | 21.76 | | 628.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 1992-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 2021-07-31 |
Reinilde Heyrman
CTO | Chief Tech/Sci/R&D Officer | 65 | 2017-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 1992-06-30 |
Robert Kraft
BRD | Director/Board Member | 55 | 2016-06-30 |
Brian Carley
BRD | Director/Board Member | 72 | 2016-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Fiscal year | Director | 56 | 0.0002% | ||
| 06-29 | Fiscal year | Director | 72 | 0.0003% | ||
| 06-29 | Fiscal year | Director | 66 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.62% | +0.45% | +66.82% | +125.87% | 15.6B | |
| -0.24% | +4.98% | +2.69% | +9.14% | 49.74B | |
| -0.36% | +1.33% | +417.51% | +619.10% | 40.49B | |
| -2.29% | +5.93% | +25.27% | +59.26% | 34.35B | |
| -2.13% | +5.47% | +25.45% | -6.01% | 34.75B | |
| -0.79% | +2.02% | +3.83% | +36.42% | 26.98B | |
| +3.82% | +3.92% | - | - | 16.58B | |
| -2.17% | +6.52% | +102.15% | +102.15% | 14.27B | |
| -2.70% | -2.19% | +11.25% | +18.19% | 13.76B | |
| -1.93% | -4.74% | +12.11% | -30.02% | 12.92B | |
| Average | -1.14% | +3.30% | +74.12% | +103.79% | 25.95B | |
| Weighted average by Cap. | -1.04% | +4.01% | +89.37% | +130.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.77B 2.43B 2.24B 2.07B 3.93B 265B 4B 26.87B 10.46B 130B 10.42B 10.19B 451B | 2.95B 2.58B 2.38B 2.2B 4.18B 282B 4.25B 28.57B 11.12B 138B 11.07B 10.83B 479B |
| Net income | 493M 432M 398M 368M 698M 47.07B 711M 4.77B 1.86B 23.08B 1.85B 1.81B 80.1B | 540M 473M 436M 403M 765M 51.6B 779M 5.23B 2.04B 25.3B 2.03B 1.98B 87.79B |
| Net Debt | -1.17B -1.02B -945M -873M -1.66B -112B -1.69B -11.32B -4.41B -54.77B -4.39B -4.29B -190B | -1.62B -1.42B -1.31B -1.21B -2.29B -155B -2.33B -15.67B -6.1B -75.8B -6.08B -5.94B -263B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | US$531.99 | -2.62% | 347,444 |
| 26-07-07 | US$546.29 | -3.33% | 357,572 |
| 26-07-06 | US$565.09 | +1.34% | 234,162 |
| 26-07-02 | US$557.60 | +2.58% | 356,575 |
| 26-07-01 | US$543.57 | +2.64% | 312,635 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
